Home > Healthcare > Medical Devices > Surgical Devices > Minimally Invasive Surgical Instrument Market

Minimally Invasive Surgical Instrument Market Size

  • Report ID: GMI7717
  • Published Date: Dec 2023
  • Report Format: PDF

Minimally Invasive Surgical Instrument Market Size

Minimally Invasive Surgical Instrument Market was valued at over USD 25.7 billion in 2023 and is anticipated to grow at a CAGR of over 8.1% between 2024 & 2032. This robust market growth can be attributed to various factors, including the increasing prevalence of chronic diseases, continual technological advancements, growing aging population, and rise in surgical volumes among others. Additionally, surging demand for cosmetic and aesthetic procedures, and increasing investments in healthcare infrastructure are also supporting the market growth.

 

Moreover, cardiovascular disorders, diabetes, and obesity are on the rise globally. Many of these diseases demand surgical intervention, and minimally invasive methods are often chosen as they have a relatively lower impact on the patient's health. The growing incidence of chronic diseases is a major factor for the adoption of MIS instruments. For instance, according to the Centers for Disease Control and Prevention, in 2022, 38.4 million Americans, or 11.6% of the U.S. population had diabetes. Furthermore, continuous advances in materials science and instrument design enable to create more durable, flexible, and efficient minimally invasive surgical devices. Instruments with enhanced ergonomics and materials, such as lightweight alloys and advanced polymers, increase surgical procedure usability and performance.
 

Minimally invasive surgical instruments are specialized tools designed for performing surgical procedures through small incisions or natural body openings. These instruments enable surgeons to access and visualize internal organs or structures with minimal disruption to surrounding tissues.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for minimally invasive surgical instrument was valued at over USD 25.7 billion in 2023 and is estimated to reach around USD 53.3 billion by 2032 attributed to the increasing prevalence of chronic diseases, continual technological advancements, and rise in the volume of surgeries among others.

The handheld instruments segment was valued at around USD 6.1 billion revenue in 2023 and is expected to grow significantly through 2032 owing to continuous advancements in portable device designs.

North America minimally invasive surgical instrument industry accounted for USD 10.2 billion revenue in 2023 and is predicted to witness substantial growth through 2032 due to continuous advancements in robotics, imaging technologies, and rising popularity of smart instruments.

Medtronic Plc, Siemens Healthineer AG, Ethicon, Inc. (Johnson & Johnson), GE Healthcare, Abbott Laboratories, Intutive Surgical, Inc., Nuvasive, Inc., Zimmer Biomet, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, CONMED Corporation, Smith & Nephew Plc., and Becton, Dickinson and Company.

Minimally Invasive Surgical Instrument Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 292
  • Countries covered: 22
  • Pages: 160
 Download Free Sample